R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13

Author:

Bray Benjamin D12,Ramagopalan Sreeram V13

Affiliation:

1. Lane Clark & Peacock, London, W1U 1DQ, UK

2. Department of Population Health Sciences, King's College London, SE1 1UL, UK

3. Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK

Abstract

In this latest update we highlight a report from the European Medicines Agency on their use of real-world evidence (RWE) in decision making, RWE reporting guidance from the Canadian Agency for Drugs and Technologies in Health and highlight some new data demonstrating the value medicines for spinal muscular atrophy have brought patients.

Publisher

Becaris Publishing Limited

Subject

Health Policy

Reference12 articles.

1. European Medicines Agency. Use of real-world evidence in regulatory decision making – EMA publishes review its studies. https://www.ema.europa.eu/en/news/use-real-world-evidence-regulatory-decision-making-ema-publishes-review-its-studies (2023).

2. Performing studies using the UK Clinical Practice Research Datalink: to link or not to link?;McDonald L;Eur. J. Epidemiol.,2018

3. Real-world data really matter;McDonald L;CMAJ.,2017

4. Lack of data sharing in observational studies;McDonald L;BMJ.,2017

5. NICE real-world evidence framework. https://www.nice.org.uk/corporate/ecd9/chapter/overview (2022).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3